Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Paul M. Campbell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3345-5007; OpenAlex author ID A5043045350. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. NetrinG1+ cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress. Co-author DOI 10.1158/2767-9764.crc-21-0147↗
  2. Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells. Last author DOI 10.1016/j.bbrc.2017.12.116↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kristopher S. Raghavan · 1 shared paper, 2022 · strength 0.13
  2. Debora Barbosa Vendramini Costa · 1 shared paper, 2022 · strength 0.13
  3. Tiffany Luong · 1 shared paper, 2022 · strength 0.13
  4. Ralph A. Francescone III · 1 shared paper, 2022 · strength 0.13
  5. Charline Ogier · 1 shared paper, 2022 · strength 0.13
  6. Janusz Franco‐Barraza · 1 shared paper, 2022 · strength 0.13
  7. Edna Cukierman · 1 shared paper, 2022 · strength 0.13
  8. Costas Andreas Lyssiotis · 1 shared paper, 2022 · strength 0.13
  9. Matthew C. Stout · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.